Xeris Pharmaceuticals Inc (NASDAQ:XERS)

5.98
Delayed Data
As of 4:00pm ET
 +0.23 / +4.00%
Today’s Change
5.30
Today|||52-Week Range
15.29
-15.18%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Xeris Pharmaceuticals Inc have a median target of 17.50, with a high estimate of 22.00 and a low estimate of 15.00. The median estimate represents a +192.64% increase from the last price of 5.98.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Xeris Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.07
Sales
$1.3M
Reporting Date
Mar 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 12.09%
 
 
 
 
 
 
Growthannually 6.76%
 
 
 

Sales

Growthquarterly 315.50%
 
 
 
 
 
 
Growthannually -13.73%
 
 
 
Key to the earnings and sales forecast charts.